COMMUNIQUÉS West-GlobeNewswire
-
Ipsen - November 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
08/12/2025 -
Ipsen - Novembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
08/12/2025 -
Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care
08/12/2025 -
Nelipak® Acquires Merrill’s Packaging
08/12/2025 -
International study offers new path to reduce spinal taps in young infants with fevers
08/12/2025 -
Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting
08/12/2025 -
Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial
08/12/2025 -
Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML
08/12/2025 -
March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting
08/12/2025 -
Wake Radiology’s Dr. Monica Reddy Recognized as a National Leader on the Radiology Business Forty Under 40 List
08/12/2025 -
SafeSpace Global (SSGC) Announces Strategic Partnership With 911inform to Transform School Safety Across America
08/12/2025 -
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
08/12/2025 -
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
08/12/2025 -
UMC Utrecht Selects PathAI’s AISight® Dx to Accelerate Research on AI Pathology Algorithms
08/12/2025 -
Sharecare partners with CLEAR to power trusted digital identity for AskMD, enable secure access to personalized clinical care and benefits
08/12/2025 -
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
08/12/2025 -
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer
08/12/2025 -
rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open
08/12/2025 -
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
08/12/2025
Pages